Sign in
CompletedPhase 4

Changes in Eye Shape With Myopia Management Interventions

Key facts

Who runs it
Ohio State University
Where
Columbus, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 4
People taking part
75 people enrolled
Started
1 Aug 2024
Ended
4 Sept 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Atropine Ophthalmic
  • MiSight 1-day disposable contact lenses
Record updated
5 November 2026

Who can take part

Age
21 years to 30 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • best corrected visual acuity of 20/25 or better in each eye
  • nearsighted
  • current contact lens wearer
  • normal binocular vision (to be determined by an examiner at the first study visit)

Who cannot take part

  • eye diseases (including lazy eye or eye turn)
  • history of refractive surgery (e.g., LASIK)
  • history of myopia control treatment
  • pregnant, nursing, or planning a pregnancy in the next 12 months
  • sensitivity to anesthetics or preservative in eye drops
  • difficulty with pupillary dilation

Where in United States

  • The Ohio State UniversityColumbus, United States

About the trial

What the trial wants to find out

The goal of this clinical trial is to study changes in eye shape of nearsighted young adults using low-dose atropine eye drops or soft multifocal contact lenses. The main questions it aims to answer are:

Read full original descriptionShow less

* do low-dose atropine and soft multifocal contact lenses affect the shape of the peripheral eye? * are changes in peripheral eye shape from these interventions influenced by changes in the focusing system of the eye?

Participants will:

* have multiple different types of photos taken * have their prescription for glasses/contacts checked * have their eye health checked, including the use of dilating eye drops * be randomly assigned to use eye drops every night or wear special contact lenses daily instead of their typical contacts * will complete five study visits over the course of 12 months

Researchers will compare young adults using low-dose atropine to those wearing soft multifocal contact lenses and to those using no intervention to see if using these interventions affects retinal shape.

The 3 groups in the trial

  • ObservationNo study treatment, for comparison

    Participants randomized to the observation arm will receive no intervention.

  • Low-dose atropineTreatment being tested

    Participants randomized to low-dose atropine will instill one drop of 0.05% atropine in each eye at bedtime for 12 months.

    Treatment: Atropine Ophthalmic

  • Soft multifocal contact lensesTreatment being tested

    Participants randomized to soft multifocal contact lenses will wear MiSight 1-day disposable contact lenses for 5-7 days per week for 12 months.

    Treatment: MiSight 1-day disposable contact lenses

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Longitudinal Changes in Eye Shape in Young Adults Treated With Low-Dose Atropine and Soft Multifocal Contact Lenses
Record updated
5 November 2026